相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer
Yuanyuan Zhang et al.
BMC MEDICINE (2022)
Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway
WenJuan Zhang et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2022)
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis
Yiwu Yan et al.
NATURE COMMUNICATIONS (2022)
A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours
Hanqun Zhang et al.
BMC MEDICAL GENOMICS (2022)
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway
Daichi Nomoto et al.
CANCER LETTERS (2022)
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
Yuqing Shen et al.
JOURNAL OF OVARIAN RESEARCH (2022)
Discovery of Potent and Selective Receptor-Interacting Serine/ Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs)
Xue Yuan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors
Shuwei Wu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
Dongjie Wang
COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE (2022)
Treatment and Management of Chronic Inflammatory Bowel Diseases: Optimizing Present and Future Therapeutic Choices
Lorenzo Bertani
JOURNAL OF CLINICAL MEDICINE (2022)
RIPK2 NODs to XIAP and IBD
Yusuf Topal et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway
Yu-Hua Hu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2021)
Knockdown of RIPK2 Inhibits Proliferation and Migration, and Induces Apoptosis via the NF-κB Signaling Pathway in Gastric Cancer
Qian Yang et al.
FRONTIERS IN GENETICS (2021)
Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling
Sameer Nikhar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
MicroRNA-146a limits tumorigenic inflammation in colorectal cancer
Lucien P. Garo et al.
NATURE COMMUNICATIONS (2021)
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease
Joerg Ermann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)
Optimization of a Series of RIPK2 PROTACs
Afjal H. Miah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Pattern recognition receptors in health and diseases
Danyang Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer
Rola F. Jaafar et al.
MEDICINA-LITHUANIA (2021)
Inflammasomes in the pathophysiology of autoinflammatory syndromes
Sarang Tartey et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Porphyromonas gingivalis Cell Wall Components Induce Programmed Death Ligand 1 (PD-L1) Expression on Human Oral Carcinoma Cells by a Receptor-Interacting Protein Kinase 2 (RIP2)-Dependent Mechanism
S. Groeger et al.
INFECTION AND IMMUNITY (2020)
Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib
Raquel Carvalho Montenegro et al.
Oncotarget (2020)
Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold
Chalada Suebsuwong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis A Review
April W. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel (vol 9, pg 1039, 2018)
Pamela A. Haile et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway
Xuming Tang et al.
CELL DEATH & DISEASE (2020)
Novel Thienopyridines as RIPK2 Inhibitors for Treating Inflammatory Bowel Disease
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2020)
Peripheral T cell clonality and exhaustion as novel biomarkers for anti-PD-1 (pembrolizumab) maintenance therapy in patients with metastatic inflammatory breast cancer (mIBC) and non-IBC triple negative breast cancer (mTNBC)
Hui Gao et al.
CANCER RESEARCH (2020)
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
Alina Mares et al.
COMMUNICATIONS BIOLOGY (2020)
A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer
Natasha C. Lucki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases
Pamela A. Haile et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Epigenome Mapping Identifies Tumor-Specific Gene Expression in Primary Rectal Cancer
Hannah Flebbe et al.
CANCERS (2019)
Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors
Curt D. Haffner et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
Hannah Strobel et al.
BIOMEDICINES (2019)
RIP2 enhances cell survival by activation of NF-κB in triple negative breast cancer cells
Rola Jaafar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors
Chalada Suebsuwong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis
Mohamed Salla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NF-κB and p38 signaling pathways
Xin Cai et al.
ONCOLOGY REPORTS (2018)
Systematic analysis of protein turnover in primary cells
Toby Mathieson et al.
NATURE COMMUNICATIONS (2018)
RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis
Alaa Zare et al.
CANCERS (2018)
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel
Pamela A. Haile et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Xiaoyue Chen et al.
NATURE COMMUNICATIONS (2018)
Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
Alison E. Freimund et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Structural basis of RIP2 activation and signaling
Qin Gong et al.
NATURE COMMUNICATIONS (2018)
NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Targeting oncogenic Myc as a strategy for cancer treatment
Hui Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment
Mariko Hirai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
From inflammation to cancer
A. Korniluk et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2017)
Antagonizing NOD2 Signaling with Conjugates of Paclitaxel and Muramyl Dipeptide Derivatives Sensitizes Paclitaxel Therapy and Significantly Prevents Tumor Metastasis
Yi Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases
Xiaohui He et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
The disparate origins of ovarian cancers: pathogenesis and prevention strategies
Anthony N. Karnezis et al.
NATURE REVIEWS CANCER (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase
Pamela A. Haile et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins et al.
NATURE (2016)
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment
Jordan E. Axelrad et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway
Leong-Perng Chan et al.
ONCOTARGET (2016)
The Inflammasomes and Autoinflammatory Syndromes
Lori Broderick et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors
Peter Canning et al.
CHEMISTRY & BIOLOGY (2015)
Primary spinal cord glioblastoma multiforme treated with temozolomide
Silvia Hernandez-Duran et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
NOD-LIKE RECEPTORS: VERSATILE CYTOSOLIC SENTINELS
Vinicius Motta et al.
PHYSIOLOGICAL REVIEWS (2015)
Polymicrobial synergy and dysbiosis in inflammatory disease
Richard J. Lamont et al.
TRENDS IN MOLECULAR MEDICINE (2015)
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production
Ueli Nachbur et al.
NATURE COMMUNICATIONS (2015)
Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
Malek Najjar et al.
CELL REPORTS (2015)
Periodontitis: from microbial immune subversion to systemic inflammation
George Hajishengallis
NATURE REVIEWS IMMUNOLOGY (2015)
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2014)
Attacking c-Myc: Targeted and Combined Therapies for Cancer
Huilin Huang et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
In Vivo Inhibition of RIPK2 Kinase Alleviates Inflammatory Disease
Justine T. Tigno-Aranjuez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Structure-Activity Relationship of 3,5-Diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants
Agustin H. Mohedas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Salivary Interleukin-6 and-8 in Patients With Oral Cancer and Patients With Chronic Oral Inflammatory Diseases
Yi-Shing Lisa Cheng et al.
JOURNAL OF PERIODONTOLOGY (2014)
NOD proteins: regulators of inflammation in health and disease
Dana J. Philpott et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways
Stina M. Singel et al.
BREAST CANCER RESEARCH (2014)
Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor
Agustin H. Mohedas et al.
ACS CHEMICAL BIOLOGY (2013)
Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes
V. U. Ozkurede et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption
Young Sun Hwang et al.
ORAL ONCOLOGY (2012)
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer
Deborah C. Rubin et al.
FRONTIERS IN IMMUNOLOGY (2012)
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells
J. Asano et al.
LEUKEMIA (2011)
Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis
Laura Stronati et al.
DIGESTIVE AND LIVER DISEASE (2010)
Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses
Justine T. Tigno-Aranjuez et al.
GENES & DEVELOPMENT (2010)
NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation
Rachel Cooney et al.
NATURE MEDICINE (2010)
The Kinase Activity of Rip2 Determines Its Stability and Consequently Nod1-and Nod2-mediated Immune Responses
Chiara Nembrini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Turnover of the Human Proteome: Determination of Protein Intracellular Stability by Dynamic SILAC
Mary K. Doherty et al.
JOURNAL OF PROTEOME RESEARCH (2009)
XIAP mediates NOD signaling via interaction with RIP2
Andreas Krieg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Pim kinase-dependent inhibition of c-Myc degradation
Y. Zhang et al.
ONCOGENE (2008)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma
Koichi Matsuzaki et al.
HEPATOLOGY (2007)
Ubiquitin-mediated activation of TAK1 and IKK
A. Adhikari et al.
ONCOGENE (2007)
New treatment strategies for malignant gliomas
Sith Sathornsumetee et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Is periodontitis associated with oral neoplasms?
M Tezal et al.
JOURNAL OF PERIODONTOLOGY (2005)
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
CM Shachaf et al.
NATURE (2004)
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor
CJ Fox et al.
GENES & DEVELOPMENT (2003)
Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation
O Gutierrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inflammatory bowel disease
DK Podolsky
NEW ENGLAND JOURNAL OF MEDICINE (2002)
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems
K Kobayashi et al.
NATURE (2002)
Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB
Y Ogura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Hepatocellular carcinoma
S Badvie
POSTGRADUATE MEDICAL JOURNAL (2000)
分享论文
